These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22293962)

  • 1. [3H](+)MK801 radioligand binding assay at the N-methyl-D-aspartate receptor.
    Reynolds IJ
    Curr Protoc Pharmacol; 2001 May; Chapter 1():Unit 1.20. PubMed ID: 22293962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional variations in [3H]MK801 binding to rat brain N-methyl-D-aspartate receptors.
    Reynolds IJ; Palmer AM
    J Neurochem; 1991 May; 56(5):1731-40. PubMed ID: 1826521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenic acid analogues with improved affinity and selectivity for the glycine site on the N-methyl-D-aspartate receptor from rat brain.
    Foster AC; Kemp JA; Leeson PD; Grimwood S; Donald AE; Marshall GR; Priestley T; Smith JD; Carling RW
    Mol Pharmacol; 1992 May; 41(5):914-22. PubMed ID: 1375317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.
    Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M
    Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T; Marshall GR; Hill RG; Kemp JA
    Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of [3H]MK-801 binding to NMDA receptors in vivo and in vitro.
    Murray F; Kennedy J; Hutson PH; Elliot J; Huscroft I; Mohnen K; Russell MG; Grimwood S
    Eur J Pharmacol; 2000 Jun; 397(2-3):263-70. PubMed ID: 10844123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric modulation of [3H]dizocilpine binding to N-methyl-D-aspartate receptor by an endogenous Na+, K+-ATPase inhibitor: dependence on receptor activation.
    Reinés A; Peña C; Rodríguez de Lores Arnaiz G
    Brain Res; 2004 Jan; 996(1):117-25. PubMed ID: 14670638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dantrolene antagonizes the glycineB site of the NMDA receptor.
    Salinska E; Sobczuk A; Lazarewicz JW
    Neurosci Lett; 2008 Feb; 432(2):137-40. PubMed ID: 18191027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterisation of the binding of [3H]MDL 105,519, a radiolabelled antagonist for the N-methyl-D-aspartate-associated glycine site, to pig cortical brain membranes.
    Höfner G; Wanner KT
    Neurosci Lett; 1997 Apr; 226(2):79-82. PubMed ID: 9159494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of (+)-HA-966, CGS-19755, phencyclidine, and dizocilpine on repeated acquisition of response chains in pigeons: systemic manipulation of central glycine sites.
    Campbell CM; Butelman ER; Woods JH
    J Pharmacol Exp Ther; 1999 Apr; 289(1):521-7. PubMed ID: 10087045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo characterization of [3H]CNS-5161--a use-dependent ligand for the N-methyl-D-aspartate receptor in rat brain.
    Biegon A; Gibbs A; Alvarado M; Ono M; Taylor S
    Synapse; 2007 Aug; 61(8):577-86. PubMed ID: 17455246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analogs of 3-hydroxy-1H-1-benzazepine-2,5-dione: structure-activity relationship at N-methyl-D-aspartate receptor glycine sites.
    Guzikowski AP; Cai SX; Espitia SA; Hawkinson JE; Huettner JE; Nogales DF; Tran M; Woodward RM; Weber E; Keana JF
    J Med Chem; 1996 Nov; 39(23):4643-53. PubMed ID: 8917653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regionally distinct stoichiometry for N-methyl-D-aspartate receptor domains in brain.
    Matsunaga T; Mukhin AG; London ED
    Neuroreport; 1996 Feb; 7(3):833-7. PubMed ID: 8733756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioligand binding assays for the glycine site on N-methyl-D-aspartate receptors.
    Perschke S; Ferkany J
    Curr Protoc Pharmacol; 2002 Aug; Chapter 1():Unit 1.27. PubMed ID: 22294074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Block of the N-methyl-D-aspartate receptor by remacemide and its des-glycine metabolite.
    Subramaniam S; Donevan SD; Rogawski MA
    J Pharmacol Exp Ther; 1996 Jan; 276(1):161-8. PubMed ID: 8558426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMDA receptor antagonists that bind to the strychnine-insensitive glycine site and inhibit NMDA-induced Ca2+ fluxes and [3H]GABA release.
    Reynolds IJ; Harris KM; Miller RJ
    Eur J Pharmacol; 1989 Mar; 172(1):9-17. PubMed ID: 2541002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Felbamate block of the N-methyl-D-aspartate receptor.
    Subramaniam S; Rho JM; Penix L; Donevan SD; Fielding RP; Rogawski MA
    J Pharmacol Exp Ther; 1995 May; 273(2):878-86. PubMed ID: 7752093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inorganic iron complexes derived from the nitric oxide donor nitroprusside: competitive N-methyl-D-aspartate receptor antagonists with nanomolar affinity.
    Neijt H; Koller M; Urwyler S
    Biochem Pharmacol; 2001 Feb; 61(3):343-9. PubMed ID: 11172739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.